Universal Literature Aggregator
Supporting automated translation and systematic screening of multilingual local literature
AI-enabled local literature - ensuring compliance in diverse regions
Local literature monitoring is pivotal in pharmacovigilance, providing a critical understanding of drug safety within specific regions and safeguarding public health.
Our expertly managed AI-enabled local literature monitoring system ensures thorough scrutiny of local journals, allowing for early detection of adverse events and comprehensive pharmacovigilance accessible across multiple regions and languages.
PLG’s advanced AI technology enhances local literature screening
Practical and comprehensive local literature monitoring ensures compliance and patient safety. Our fully validated regulatory-compliant software extends its coverage across multiple countries, enabling local and central teams to monitor and eliminate reliance on various vendors. We provide content-specific information regarding local conditions, policies, and cultural practices. Using advanced features such as Optical Character Recognition (OCR) and Machine Translation (MT), our solution is entirely GVP compliant and meets the highest level of data integrity, information security, and adherence to good documentation practices. With proven efficiency and a comprehensive understanding of drug safety within specific regions, our solution provides valuable insights for a seamless pharmacovigilance operation.
KEY FIGURES
600+
Local journal sites and publications from EMA, WHO, FDA, MHRA, TGA, PMDA, Swissmedic, and local health authorities.
We are excited to embark on a new chapter in AI literature monitoring, ensuring our commitment to high-quality standards for every project.
Sophie Lequin-Cauchy
Activity Manager Literature Monitoring, ProductLife Group
You can read more about literature monitoring and our services here:
